IP Library › Assignment 032422/0064
Patent Assignment
Reel/Frame 032422/0064

Security Interest

Recorded: 2014-03-13 Pages: 52
Assignor
NOXXON PHARMA AG
Executed: 2014-03-10
Assignee
KREOS CAPITAL IV (UK) LIMITED
25-28 OLD BURLINGTON STREET, LONDON, W1S 3AN, UNITED KINGDOM
Covered Properties (6)
Mcp-1 Binding Nucleic Acids
Patent: 8,193,159 →
Application: 12/279,183 →
Publication: US 2010/0284961
Mcp-1 Binding Nucleic Acids and Use Thereof
Patent: 8,367,629 →
Application: 12/325,180 →
Publication: US 2009/0156542
Sdf-1 Binding Nucleic Acids
Patent: 8,314,223 →
Application: 12/374,311 →
Publication: US 2011/0112172
C5a binding nucleic acids
Patent: 8,507,456 →
Application: 12/679,307 →
Publication: US 2011/0046207
Use of Spiegelmers to Inhibit an Intracellular Target Molecule
Patent: 8,497,250 →
Application: 11/913,526 →
Publication: US 2009/0192100
Modified L-Nucleic Acid
Patent: 7,629,456 →
Application: 10/493,569 →
Publication: US 2006/0003326
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 20, 2006
From: LANGE, CHRISTIAN; ESCHGFALLER, BERND; KLUSSMANN, SVEN
To: NOXXON PHARMA AG
Reel/Frame 017512/0692 →
Assignment of Assignor's Interest Jan 11, 2008
From: VATER, AXEL; MAASCH, CHRISTIAN; KLUSSMANN, SVEN; PURSCHKE, WERNER
To: NOXXON PHARMA AG
Reel/Frame 020352/0332 →
Assignment of Assignor's Interest Dec 15, 2008
From: PURSCHKE, WERNER; JAROSCH, FLORIAN; EULBERG, DIRK; KLUSSMANN, SVEN
To: NOXXON PHARMA AG
Reel/Frame 021981/0958 →
Assignment of Assignor's Interest Jan 31, 2009
From: PURSCHKE, WERNER; JAROSCH, FLORIAN; EULBERG, DIRK; KLUSSMANN, SVEN
To: NOXXON PHARMA AG
Reel/Frame 022185/0085 →
Assignment of Assignor's Interest Feb 6, 2009
From: PURSCHKE, WERNER; JAROSCH, FLORIAN; EULBERG, DIRK; KLUSSMANN, SVEN
To: NOXXON PHARMA AG
Reel/Frame 022216/0668 →
Assignment of Assignor's Interest Sep 11, 2010
From: PURSCHKE, WERNER; JAROSCH, FLORIAN; EULBERG, DIRK; KLUSSMANN, SVEN
To: NOXXON PHARMA AG
Reel/Frame 024971/0903 →
Security Interest Apr 27, 2015
From: NOXXON PHARMA AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 035501/0893 →
Release of Security Interest Feb 7, 2020
From: KREOS CAPITAL IV (UK) LIMITED
To: NOXXON PHARMA AG
Reel/Frame 051757/0649 →
Change of Name Jan 26, 2023
From: NOXXON PHARMA AG
To: TME PHARMA AG
Reel/Frame 062489/0829 →